FDA regulation of off-label drug promotion under attack

JAMA. 2013 Feb 6;309(5):445-6. doi: 10.1001/jama.2012.207972.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Advertising
  • Drug Industry / economics
  • Drug Industry / ethics
  • Education, Medical / economics
  • Education, Medical / ethics
  • Humans
  • Legislation, Drug*
  • Off-Label Use / ethics
  • Off-Label Use / legislation & jurisprudence*
  • Speech
  • Truth Disclosure
  • United States
  • United States Food and Drug Administration / legislation & jurisprudence*